RUDIVAX (RUBELLA) VACCINE Injection
Rubella virus, live attenuated
at least 1000 TCID50/Dose
PASTEUR-MERIEUX
| Pack size | 1 Dose Vial x 10 + 10 Ampoule Diluent |
|---|---|
| Dispensing mode | POM |
| Source | FRANCE |
| Agent | NEW MEDICAL CENTRE |
| Retail Price | 275.50 AED |
Indications
RUDIVAX (RUBELLA) VACCINE Injection is used for:
The rubella vaccine should be administered to non-pregnant females who have tested nonimmune or have a rubella titer less than 1:10. As rubella causes upper respiratory disease that leads to complications of pneumonia and bronchitis, rubella vaccine is beneficial to control exacerbations of chronic obstructive pulmonary disease (COPD) and asthma.
Adult Dose
Child Dose
Renal Dose
Administration
Contra Indications
Precautions
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Rubella virus, live attenuated :
Mechanism of Action
Note
RUDIVAX (RUBELLA) VACCINE at least 1000 TCID50/Dose Injection manufactured by PASTEUR-MERIEUX. Its generic name is Rubella virus, live attenuated. RUDIVAX (RUBELLA) VACCINE is availble in United Arab Emirates.
Farmaco UAE drug index information on RUDIVAX (RUBELLA) VACCINE Injection is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.